Skip to Search Skip to Navigation Skip to Main Content Skip to Footer
  • FAQs
  • Government
  • Non-Government
  • Maps & Visuals
  • About this Portal
  • Browse All
  • Provide Feedback
  • Recommend a Resource

User Login

Administration Login
  • About this Portal
  • Browse All
  • Provide Feedback
  • Recommend a Resource

COVID-19 Information

An Open Access Initiative
Menu

menu

  • FAQs
  • Government
  • Non-Government
  • Maps & Visuals
  • Area/Country
  • Clinical Care
  • Research
  • News

RSS Feed

Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
Diabetes action plan focuses on prevention, care, and social determinants of health
Chair File: Leadership Dialogue — Discussing Creative Approaches to Health Care Challenges with Wright L. Lassiter III
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors
Artificial Tears, Tear Lipids and Tear Film Dynamics

Pages

  • « first
  • ‹ previous
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • next ›
  • last »
    

Copyright © 2023 Powered By EBSCO Stacks 3.3.0 [348] | Administration Login

  • Privacy
  • GDPR
  • Privacy Policy
  • EBSCO Connect
  • COVID-19 Clinical Care Portal

EBSCO Information Services, a long-time research content aggregator, is now a leading provider of evidence-based clinical decision support solutions, shared decision making tools, medical research information and healthcare business intelligence. We’re working with industry leaders to provide evidence-based and authoritative resources regarding the COVID-19 pandemic to meet the information needs of healthcare professionals, medical researchers, librarians, and health information professionals. To learn more, visit health.ebsco.com.

Workflow: 
Published

Workflow: 
Published